• Add this page to "Favorite pages"
  • Print Text
Here begins the text.

PMDA-ATC Pharmaceuticals Review Seminar 2017

Introduction

  The Pharmaceuticals and Medical Devices Agency (PMDA) is pleased to announce the holding of the "PMDA-ATC Pharmaceuticals Review Seminar 2017" for officials from overseas regulatory authorities who are engaged in the review of pharmaceuticals.
  The Seminar will be offered by the Asia Training Center for Pharmaceuticals and Medical Devices Regulatory Affairs (PMDA-ATC) at PMDA Office in Tokyo, from June 26-30, 2017.
  At the Seminar, the details of regulatory activities for pharmaceuticals including consultation and product reviews will be shared.  Case studies and discussions among participants are planned as well.
  The aims of the Seminar are to provide chances for the participants to refer back to their work and to find any additional opportunity for enhancement of the participant's regulatory system.
  The seminar is not open to the industry or non-regulatory authorities. The seminar is not intended for Japanese government employees, either.
  Participation from many regulatory authorities is welcomed.

Key Seminar Objective

  1. To learn basics of regulations and regulatory organization
  2. To learn the key regulatory flow of the product development to post-approval

   The Seminar will focus on the following key regulatory activities.
    - Consultations (Scientific Advice)
    - Product review

  1. To make use of the learnings from case studies and discussions and reflect it

   back to the regulatory system in the participant's organization

Who should apply

  • Officials from regulatory authorities who are currently engaged in the review of pharmaceuticals.
  • A basic knowledge of the regulations pertaining to the pharmaceutical product review in his/her organization is required.

    - The training will be provided in English (with simultaneous translation in some sessions).
    - All participants are expected to actively participate in all of the sessions.

Date / Time

June 26 to 30, 2017. See attached program for draft schedule.

Program (subject to change)

See attached for the draft program

Registration

  • Registration request should be made by filling in all the necessary items on the application form and sending it by e-mail to PMDA-ATC@pmda.go.jp
  • Registration will close on April 14, 2017.
  • Early registration is recommended. The registration may close before the deadline depending on the number of application. Also, please be sure to allow enough time to obtain the visa for entry to Japan.
  • If the number of applications exceeds the capacity, the number of participants from each country may be limited.
  • Confirmation of the registration and additional meeting information will be sent to the approved participants after the close of registration.

Fee

There is no registration fee for this seminar.
Information on travel and hotel reservation assistance will be announced to the approved participants.

Location

Pharmaceuticals and Medical Devices Agency (PMDA):

Shin-kasumigaseki Building, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan

Access

MAP

Please use public transportation. Nearest Tokyo Metro Subway Stations:

  • 5 minutes' walk from Exit 11 of Toranomon Station on the Ginza Line
  • 8 minutes' walk from Exit 3 of Kokkai-gijido-mae Station, on the Marunouchi Line, Chiyoda Line
  • 8 minutes' walk from Exit A13 of Kasumigaseki Station, on the Marunouchi Line, Chiyoda Line, Hibiya Line
  • 10 minutes' walk from Exit 8 of Tameike-sanno Station, on the Ginza Line, Nanboku Line

Contact Us

For more information, please contact:
   Secretariat, PMDA Asia Training Center
   E-mail: PMDA-ATC@pmda.go.jp

   Office of International Cooperation
   Pharmaceuticals and Medical Devices Agency
   Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013 Japan

Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.